{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T10:37:27Z","timestamp":1725878247466},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1007\/bf01276563","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T06:16:59Z","timestamp":1111645019000},"page":"35-46","source":"Crossref","is-referenced-by-count":12,"title":["D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function"],"prefix":"10.1007","volume":"102","author":[{"given":"S. C.","family":"Cheetham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"Kettle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Heal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","volume":"166","author":"PH Andersen","year":"1989","unstructured":"Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166: 493?504","journal-title":"Eur J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/0024-3205(85)90028-1","volume":"37","author":"PH Andersen","year":"1985","unstructured":"Andersen PH, Gr\u00f8nvald FC, Jansen JA (1985) A comparison between dopamine-stimulated adenylate cyclase and3H-SCH 23390 binding in rat striatum. Life Sci 37: 1971?1983","journal-title":"Life Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","volume":"324","author":"RJ Baldessarini","year":"1991","unstructured":"Baldessarini RJ, Frankenburg FR (1991) Clozapine a novel antipsychotic agent. N Engl J Med 324: 746?754","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0006-8993(90)90829-Z","volume":"529","author":"AI Barkai","year":"1990","unstructured":"Barkai AI, Durkin M, Nelson HD (1990) Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study. Brain Res 529: 208?213","journal-title":"Brain Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/0024-3205(84)90540-X","volume":"35","author":"W Billard","year":"1984","unstructured":"Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A (1984) Characterization of the binding of3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci 35: 1885?1893","journal-title":"Life Sci"},{"issue":"1","key":"CR6","first-page":"T 13.11.26","volume":"72","author":"C Bowden","year":"1994","unstructured":"Bowden C, Cheetham SC, Crompton MR, Katona CLE, de Paermentier F, Theodorou AE, Horton RW (1994a) Dopamine and its metabolites in depressed suicide victims. Can J Physiol Pharmacol 72(1): T 13.11.26","journal-title":"Can J Physiol Pharmacol"},{"key":"CR7","unstructured":"Bowden C, Cheetham SC, Crompton MR, Katona CLE, de Paermentier F, Theodorou AE, Horton RW (1994b) Dopamine D1 and D2 receptor binding sites in depressed suicide victims. Br J Pharmacol 110: 2P"},{"key":"CR8","unstructured":"Cheetham SC, Viggers JA, Slater NA, Buckett WR (1990) Inhibition of [3H]paroxetine binding by sibutramine, its metabolites and other antidepressants correlates with inhibition of [3H]5-hydroxytryptamine uptake. Br J Pharmacol 101: 515P"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y-C Cheng","year":"1973","unstructured":"Cheng Y-C, Prusoff WH (1973) Relationship between inhibition constant (Ki) and the concentration of the inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099?3108","journal-title":"Biochem Pharmacol"},{"key":"CR10","first-page":"1093","volume":"247","author":"RE Chipkin","year":"1988","unstructured":"Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A (1988) Pharmacological profile of SCH 39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity. J Pharmacol Exp Ther 247: 1093?1102","journal-title":"J Pharmacol Exp Ther"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(85)90549-7","volume":"109","author":"I Creese","year":"1985","unstructured":"Creese I, Chen A (1985) Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390. Eur J Pharmacol 109: 127?128","journal-title":"Eur J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(90)90589-X","volume":"180","author":"GM Montis De","year":"1990","unstructured":"De Montis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A (1990) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol 180: 31?35","journal-title":"Eur J Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0006-2952(89)90387-0","volume":"38","author":"G Faedda","year":"1989","unstructured":"Faedda G, Kula NS, Baldessarini RJ (1989) Pharmacology of binding of3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. Biochem Pharmacol 38: 473?480","journal-title":"Biochem Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/0006-2952(83)90397-0","volume":"32","author":"S Fleminger","year":"1983","unstructured":"Fleminger S, Rupniak NMJ, Hall MD, Jenner P, Marsden CD (1983) Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not increases in D-1 receptors. Biochem Pharmacol 32: 2921?2927","journal-title":"Biochem Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0028-3908(81)90107-6","volume":"20","author":"M Globus","year":"1981","unstructured":"Globus M, Lerer B, Hamburger R, Belmaker RH (1981) Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors. Neuropharmacology 20: 1125?1128","journal-title":"Neuropharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00439110","volume":"52","author":"AR Green","year":"1977","unstructured":"Green AR, Heal DJ, Grahame-Smith DG (1977) Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology 52: 195?200","journal-title":"Psychopharmacology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-4159.1989.tb07389.x","volume":"53","author":"DJ Heal","year":"1989","unstructured":"Heal DJ, Butler SA, Hurst EM, Buckett WR (1989) Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease ?1 but not ?2-adrenoceptors in rat cortex. J Neurochem 53: 1019?1025","journal-title":"J Neurochem"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0278-5846(94)90086-8","volume":"18","author":"DJ Heal","year":"1994","unstructured":"Heal DJ, Czudek C, Buckett WR (1994) Common profile of D1 receptor antagonists and atypical antipsychotic drugs revealed by analysis of dopamine turnover. Prog Neuropsychopharmacol Biol Psychiatry 18: 803?821","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02244212","volume":"103","author":"DJ Heal","year":"1991","unstructured":"Heal DJ, Prow MR, Buckett WR (1991) Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic ?2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride. Psychopharmacology 103: 251?257","journal-title":"Psychopharmacology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel J (1983) SCH 23390 ? the first selective dopamine D-1 antagonist. Eur J Pharmacol 91: 153?154","journal-title":"Eur J Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0773.1986.tb00189.x","volume":"59","author":"J Hyttel","year":"1986","unstructured":"Hyttel J (1986) Effect of prolonged treatment with neuroleptics on D-1 and D-2 receptor number in corpus striatum of rat and mouse. Acta Pharmacol Toxicol Copenh 59: 387?391","journal-title":"Acta Pharmacol Toxicol Copenh"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02098496","volume":"68","author":"J Hyttel","year":"1987","unstructured":"Hyttel J, Arnt J (1987) Characterization of binding of3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions. J Neural Transm 68: 171?189","journal-title":"J Neural Transm"},{"key":"CR23","first-page":"462","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226: 462?468","journal-title":"J Pharmacol Exp Ther"},{"key":"CR24","first-page":"1285","volume":"20","author":"P Jenner","year":"1981","unstructured":"Jenner P, Marsden CD (1981) Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 20: 1285?1293","journal-title":"Neuropharmacology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0014-2999(89)90362-2","volume":"166","author":"DJ Kerkman","year":"1989","unstructured":"Kerkman DJ, Ackerman M, Artman LD, MacKenzie RG, Johnson MC, Bednarz L, Montana W, Asin KE, Stampfli H, Kebabian JW (1989) A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor. Eur J Pharmacol 166: 481?491","journal-title":"Eur J Pharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(87)90248-2","volume":"139","author":"V Klimek","year":"1987","unstructured":"Klimek V, Nielsen M (1987) Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system. Eur J Pharmacol 139: 163?169","journal-title":"Eur J Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(92)90421-5","volume":"575","author":"M Laruelle","year":"1992","unstructured":"Laruelle M, Jaskiw GE, Lipska BK, Kolachana B, Casanova MF, Kleinman JE, Weinberger DR (1992) D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment. Brain Res 575: 47?56","journal-title":"Brain Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.89.17.8155","volume":"89","author":"D L\u00e9vesque","year":"1992","unstructured":"L\u00e9vesque D, Diaz J, Pilon C, Martres M-P, Giros B, Souil E, Schott D, Morgat J-L, Schwartz J-C, Sokoloff P (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89: 8155?8159","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265?275","journal-title":"J Biol Chem"},{"key":"CR30","unstructured":"Martin KF, Needham PL, Atkinson J, Cowan A, Heal DJ, Buckett WR (1988) Rat striatal and mesolimbic D1 receptor binding is not altered by antidepressant treatments including ECS and sibutramine HCl. Br J Pharmacol 95: 896P"},{"key":"CR31","first-page":"498","volume":"265","author":"S Matsubara","year":"1993","unstructured":"Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I (1993) Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265: 498?508","journal-title":"J Pharmacol Exp Ther"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/syn.890030111","volume":"3","author":"P McGonigle","year":"1989","unstructured":"McGonigle P, Boyson SJ, Reuter S, Molinoff PB (1989) Effect of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse 3: 74?82","journal-title":"Synapse"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0010-468X(83)90031-4","volume":"17","author":"GA McPherson","year":"1983","unstructured":"McPherson GA (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed 17: 107?113","journal-title":"Comput Programs Biomed"},{"key":"CR34","first-page":"656","volume":"233","author":"E Meller","year":"1985","unstructured":"Meller E, Bohmaker K, Goldstein M, Friedhoff AJ (1985) Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics. J Pharmacol Exp Ther 233: 656?662","journal-title":"J Pharmacol Exp Ther"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01243434","volume":"36","author":"K Modigh","year":"1975","unstructured":"Modigh K (1975) Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. J Neural Transm 36: 19?32","journal-title":"J Neural Transm"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(80)90515-1","volume":"107","author":"PJ Munson","year":"1980","unstructured":"Munson PJ, Rodbard D (1980) LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Anal Biochem 107: 220?239","journal-title":"Anal Biochem"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(89)90594-3","volume":"167","author":"G Nowak","year":"1989","unstructured":"Nowak G, Zak J (1989) Repeated electroconvulsive shock (ECS) enhances striatal D-1 dopamine receptor turnover in rats. Eur J Pharmacol 167: 307?308","journal-title":"Eur J Pharmacol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0028-3908(89)90036-1","volume":"28","author":"KM O'Boyle","year":"1989","unstructured":"O'Boyle KM, Gaitanopoulos DE, Brenner M, Waddington JL (1989) Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology 28: 401?405","journal-title":"Neuropharmacology"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00711239","volume":"12","author":"PR Paetsch","year":"1992","unstructured":"Paetsch PR, Greenshaw AJ (1992) Effects of chronic antidepressant treatment on dopaminerelated [3H]SCH 23390 and [3H]spiperone binding in the rat striatum. Cell Mol Neurobiol 12: 597?606","journal-title":"Cell Mol Neurobiol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-2999(85)90151-7","volume":"118","author":"ML Porceddu","year":"1985","unstructured":"Porceddu ML, Ongini E, Biggio G (1985) [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors. Eur J Pharmacol 118: 367?370","journal-title":"Eur J Pharmacol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00003495-198937050-00006","volume":"37","author":"MV Rudorfer","year":"1989","unstructured":"Rudorfer MV, Potter WZ (1989) Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the ?newer? versus the ?older? drugs. Drugs 37: 713?738","journal-title":"Drugs"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02245799","volume":"100","author":"T Sharp","year":"1990","unstructured":"Sharp T, Kingston J, Grahame-Smith DG (1990) Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats. Psychopharmacology 100: 110?114","journal-title":"Psychopharmacology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/294366a0","volume":"294","author":"JC Stoof","year":"1981","unstructured":"Stoof JC, Kebabian JW (1981) Opposing roles for the D-1 and D-2 dopamine receptors in efflux of cAMP from rat neostriatum. Nature 294: 366?368","journal-title":"Nature"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2999(86)90358-4","volume":"129","author":"JC Stoof","year":"1986","unstructured":"Stoof JC, Verheijden PFHM (1986) D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens. Eur J Pharmacol 129: 205?206","journal-title":"Eur J Pharmacol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","volume":"350","author":"RK Sunahara","year":"1991","unstructured":"Sunahara RK, Guan H-C, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HHM, Niznik HB (1991) Cloning of the gene for a human dopamine D5receptor with higher affinity for dopamine than D1. Nature 350: 614?619","journal-title":"Nature"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","volume":"350","author":"HHM Tol Van","year":"1991","unstructured":"Van Tol HHM, Bunzow JR, Guan H-C, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991) Cloning of the gene for a human D4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610?614","journal-title":"Nature"},{"key":"CR47","first-page":"542","volume":"184","author":"PF Voigtlander Von","year":"1973","unstructured":"Von Voigtlander PF, Moore KE (1973) Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J Pharmacol Exp Ther 184: 542?552","journal-title":"J Pharmacol Exp Ther"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/clpt.1991.144","volume":"50","author":"M Weintraub","year":"1991","unstructured":"Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML (1991) Sibutramine in weight control: a dose-ranging, efficacy study. Clin Pharmacol Ther 50: 330?337","journal-title":"Clin Pharmacol Ther"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0028-3908(81)90024-1","volume":"20","author":"M Wielosz","year":"1981","unstructured":"Wielosz M (1981) Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats. Neuropharmacology 20: 941?945","journal-title":"Neuropharmacology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01276563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01276563\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01276563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:18:15Z","timestamp":1625638695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01276563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["BF01276563"],"URL":"https:\/\/doi.org\/10.1007\/bf01276563","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}